These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23527719)
1. Evaluation of the expression and role of IGF pathway biomarkers in human sarcomas. Lin F; Shen Z; Xu X; Hu BB; Meerani S; Tang LN; Zheng SE; Sun YJ; Min DL; Yao Y Int J Immunopathol Pharmacol; 2013; 26(1):169-77. PubMed ID: 23527719 [TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors. Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888 [TBL] [Abstract][Full Text] [Related]
3. The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor. Chen KT; Hour MJ; Tsai SC; Chung JG; Kuo SC; Lu CC; Chiu YJ; Chuang YH; Yang JS Int J Oncol; 2011 Sep; 39(3):611-9. PubMed ID: 21667022 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma. Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554 [TBL] [Abstract][Full Text] [Related]
5. Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas. Potratz JC; Saunders DN; Wai DH; Ng TL; McKinney SE; Carboni JM; Gottardis MM; Triche TJ; Jürgens H; Pollak MN; Aparicio SA; Sorensen PH Cancer Res; 2010 Nov; 70(21):8770-81. PubMed ID: 20959493 [TBL] [Abstract][Full Text] [Related]
6. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling. Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464 [TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways. Zhang J; Chen B; Li H; Wang Y; Liu X; Wong KY; Chan WN; Chan AK; Cheung AH; Leung KT; Dong Y; Pan Y; Ke H; Liang L; Zhou Z; Xiao J; Wong CC; Wu WK; Cheng AS; Ma BB; Yu J; Lo KW; Kang W; J Pathol; 2023 Feb; 259(2):205-219. PubMed ID: 36373776 [TBL] [Abstract][Full Text] [Related]
8. Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells. Chen YW; Boyartchuk V; Lewis BC Neoplasia; 2009 Sep; 11(9):835-45. PubMed ID: 19724677 [TBL] [Abstract][Full Text] [Related]
9. Epithelial IGF1R is dispensable for IGF2 mediated enhanced intestinal adaptation in retinoblastoma-deficient mice. Sun RC; Choi PM; Diaz-Miron JL; Sommovilla J; Guo J; Erwin CR; Warner BW J Pediatr Surg; 2017 Jun; 52(6):1026-1030. PubMed ID: 28343662 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models. Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2. Xie M; Sun M; Ji X; Li D; Chen X; Zhang B; Huang W; Zhang T; Wang Y; Tian D; Xia L Theranostics; 2022; 12(3):1097-1116. PubMed ID: 35154476 [No Abstract] [Full Text] [Related]
12. IGF2 is highly expressed in pediatric undifferentiated sarcomas and reveals two distinct cytoplasmic trafficking patterns. Somers GR; Ho M; Pienkowska M; Shlien A; Malkin D; Ackerley C; Zielenska M Pediatr Dev Pathol; 2010; 13(3):169-77. PubMed ID: 19586133 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. Sekyi-Otu A; Bell RS; Ohashi C; Pollak M; Andrulis IL Cancer Res; 1995 Jan; 55(1):129-34. PubMed ID: 7805022 [TBL] [Abstract][Full Text] [Related]
14. Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumours. Italiano A; Chen J; Zhang L; Hajdu M; Singer S; DeMatteo RP; Antonescu CR Eur J Cancer; 2012 Nov; 48(17):3215-22. PubMed ID: 22770876 [TBL] [Abstract][Full Text] [Related]
15. Transcriptome profiling of Ewing sarcomas - treatment resistance pathways and IGF-dependency. Chen Y; Hesla AC; Lin Y; Ghaderi M; Liu M; Yang C; Zhang Y; Tsagkozis P; Larsson O; Haglund F Mol Oncol; 2020 May; 14(5):1101-1117. PubMed ID: 32115849 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress. Li T; Wang J; Liu P; Chi J; Yan H; Lei L; Li Z; Yang B; Wang X Oncotarget; 2017 Jul; 8(29):47269-47283. PubMed ID: 28521298 [TBL] [Abstract][Full Text] [Related]